Role of Natural Antioxidants from Functional Foods in Neurodegenerative and Metabolic DisordersView this Special Issue
Polyphenol Stilbenes from Fenugreek (Trigonella foenum-graecum L.) Seeds Improve Insulin Sensitivity and Mitochondrial Function in 3T3-L1 Adipocytes
Fenugreek (Trigonella foenum-graecum L.) is a well-known annual plant that is widely distributed worldwide and has possessed obvious hypoglycemic and hypercholesterolemia characteristics. In our previous study, three polyphenol stilbenes were separated from fenugreek seeds. Here, we investigated the effect of polyphenol stilbenes on adipogenesis and insulin resistance in 3T3-L1 adipocytes. Oil Red O staining and triglyceride assays showed that polyphenol stilbenes differently reduced lipid accumulation by suppressing the expression of adipocyte-specific proteins. In addition, polyphenol stilbenes improved the uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose (2-NBDG) by promoting the phosphorylation of protein kinase B (AKT) and AMP-activated protein kinase (AMPK). In present studies, it was found that polyphenol stilbenes had the ability to scavenge reactive oxygen species (ROS). Results from adenosine triphosphate (ATP) production and mitochondrial membrane potentials suggested that mitochondria play a critical role in insulin resistance and related signaling activation, such as AKT and AMPK. Rhaponticin, one of the stilbenes from fenugreek, had the strongest activity among the three compounds in vitro. Future studies will focus on mitochondrial biogenesis and function.
Fenugreek (Trigonella foenum-graecum L.) is a well-known annual plant that belongs to the legume family and is widely distributed in China, India, and North African countries . Fenugreek has been widely used as an edible vegetable and a medicinal plant for decades . The seeds and some of its fractions have been reported to possess a wide range of biological and pharmacological effects [3, 4], including antioxidant [5, 6], hypoglycemic [7–10], hypercholesterolemia [11–13], and immunomodulatory activities . Different beneficial functions of fenugreek are related to the variety of its natural components . Fenugreek has been reported to contain galactomannans, nicotinic acid, alkaloids, flavonoids, salicylate, and amino acids . Although several studies have shown that fenugreek seeds lowered blood glucose levels and improved lipid metabolism, the effective components are yet unknown. In our previous study, we successfully separated and purified several compounds from fenugreek seed extracts, including unsaturated fatty acids , flavonoids, and polyphenolic substances [18, 19]. To the best of our knowledge, it is the first report that polyphenol stilbenes (rhaponticin, desoxyrhaponticin, rhapontigenin) from Trigonella foenum-graecum L. seeds can be separated by high-speed counter-current chromatography (HSCCC) (Figure 1) .
Polyphenol compounds are composed of a group of substances with different chemical structures and activities and are widely present in nature . Among a large variety of plant phenols, stilbenes have recently attracted extensive scientific attention. Resveratrol (3,5,4-trihydroxy-trans-stilbene) is a well-known polyphenol compound that has widespread activities including antiobesity, antidiabetic, cardiovascular protective, and neuroprotective properties . Recent studies have suggested that other polyphenol stilbenes may have a similar or even higher bioavailability compared to resveratrol . Although several reports are available on the active components in fenugreek, little is known about the impact of polyphenol stilbenes on the glucose and lipid metabolism and its mechanisms of action have not yet been elucidated.
In our previous study, we demonstrated hypoglycemic effects of fenugreek extracts on streptozotocin- (STZ-) induced type 2 diabetic mice that were given with a high-fat diet. The results implied that the antidiabetic effects of stilbene extracts were related to their antioxidant effects . Therefore, in the current study, we investigated the effects of polyphenol stilbenes from fenugreek seeds on both lipid accumulation and insulin resistance in 3T3-L1 adipocytes in vitro. To explore the underlying mechanisms of action, modulation of these stilbenes on the AMPK pathway and reactive oxygen species (ROS) was also discussed.
2. Materials and Methods
2.1. Differentiation of 3T3-L1 Preadipocytes and Induction of Insulin-Resistant Adipocytes
3T3-L1 cells were obtained from the cell bank of the Institute of Biochemistry and Cell Biology of Shanghai (Shanghai, China). Preadipocytes were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) containing 10% calf serum (CS), 1.5 g/L sodium bicarbonate, and 1% penicillin-streptomycin solution. Cells were cultured at 37°C in a humidified atmosphere containing 5% CO2, and medium was replaced every other day until cells were confluent. As previously described , 3T3-L1 cells fully differentiated to mature adipocytes and induced to insulin-resistant adipocytes  (Figure 2).
2.2. Cell Viability Assay
All tested compounds were obtained from the Key Laboratory of Tibetan Medicine Research, Northwest Institute of Plateau Biology, Chinese Academy of Sciences (Xining, China) and included rhaponticin (RHAc), desoxyrhaponticin (dRHAc), and rhapontigenin (RHAg). Cell viability was assessed by the lactate dehydrogenase (LDH) assay. 3T3-L1 preadipocytes were seeded in 96-well plates (0.5 × 104 cells/well) in DMEM medium without sodium pyruvate and containing 10% fetal bovine serum (FBS). Cells were incubated for 24 hr at 37°C until confluency and were separately treated with 0–100 μmol/L RHAc, dRHAc, and RHAg for 48 hr. Then, medium was transferred to 1.5 mL microcentrifuge tubes and centrifuged at 12,000 ×g and 4°C for 10 min to remove any cell debris. A total of 500 μL supernatant was added to the substrate solution, and the absorbance at 490 nm was measured using a spectrophotometer (Spectra MRTM, Dynex Technologies, Chantilly, VA, USA) according to the manufacturer’s instructions of the LDH cytotoxicity assay kits (Beyotime Biotech Co., Beijing, China). The extracellular LDH activity in the media of normal control group was expressed as 100%.
2.3. Oil Red O Staining
To evaluate the effects of RHAc, dRHAc, and RHAg on lipid accumulation in 3T3-L1 adipocytes, cells were pretreated with 10 μmol/L per compound for 2 days before maturation was initiated. 3T3-L1 preadipocytes were differentiated as mentioned above on Lab-Tek® chambered cover glasses (Nalge Nunc International, Naperville, IL, USA). After induction of insulin resistance and pretreatment of the compounds, respectively, 3T3-L1 mature adipocytes were gently washed with PBS and fixed in 10% neutral formalin. Cells were permeated using 0.5% Triton-X 100 and stained with filtered Oil Red O solution (60% isopropanol and 40% water) for 30 min at room temperature. Excess Oil Red O dye was removed by washing three times with 70% EtOH. Stained oil droplets in 3T3-L1 cells were imaged using a light microscope (Olympus, Japan).
2.4. Triglyceride Assay
To evaluate the intracellular triglyceride (TG) content, 3T3-L1 preadipocytes were cultured in 12-well plates as described under Section 2.3. At confluency, cells were washed twice in ice-cold phosphate-buffered saline (PBS) and harvested in ice-cold lysis buffer. Total TG content in the lysates was measured by using TG assay kits, and cellular protein was determined using the bicinchoninic acid (BCA) protein assay kits (Nanjing Jiancheng Bioengineering Institute, Nanjing, China).
2.5. Western Blot Analysis
As described under Section 2.3, 3T3-L1 preadipocytes were gently seeded into 6-well plates (1.5 × 105 cells/well). Before maturation or inducing insulin resistance of 3T3-L1 adipocytes, cells were separately treated with RHAc, dRHAc, and RHAg for 2 days. Then, cells were washed trice with ice-cold PBS, harvested in 200 μL lysis buffer, and lysates were centrifuged at 12,000 ×g for 20 min at 4°C. The protein content of the supernatant was determined using the BCA assay kit. Cell lysates were separated by sodium dodecyl sulfate-polyacrylamide (SDS-PAGE) gel electrophoresis, and proteins were transferred onto a polyvinylidene fluoride (PVDF) membrane using a Bio-Rad electrophoresis equipment. Membranes were blocked with 5% skim milk in Tris-buffered saline containing 0.05% Tween-20 (TBST) for 1 hr at room temperature and incubated overnight with primary antibodies (1 : 1000, Santa Cruz Biotechnology, CA, USA) at 4°C. Membranes were washed and incubated with a horseradish peroxidase- (HRP-) conjugated secondary antibody (Boster Biotech Co. Ltd., Wuhan, China) for 2 hr at room temperature. Membranes were washed and immunoreactive proteins were visualized using an enhanced chemiluminescent (ECL) assay kit (Beyotime Biotech Co., Beijing, China) according to the manufacturer’s instructions. Protein bands were analyzed using a 5200 Multi Luminescent image analyzer (Tanon Science & Technology Co. Ltd. Shanghai, China).
2.6. 2-NBDG Uptake
As described under Section 2.1, 3T3-L1 preadipocytes were gently seeded into 12-well plates (0.8 × 105 cells/well) and pretreated with RHAc, dRHAc, and RHAg for 2 days prior to induction of insulin resistance. Next, adipocytes were washed twice with PBS and the medium was changed to glucose-free DMEM containing 100 nmol/L of insulin. After 1 hr, 100 μmol/L 2-NBDG was added to the medium and cells were incubated for another 30 min. Then, cells were washed three times with PBS, trypsinized, and collected in the dark. The fluorescence was measured (excitation at 485/20 nm and emission at 540/20 nm) using a FACSAria™ flow cytometer (Becton Dickinson, San Jose, CA, USA). The data are presented as the mean fluorescent signals for 20,000 cells.
2.7. ROS Detection
As described in Section 2.6, 3T3-L1 preadipocytes were seeded into 6-well plates (1.5 × 105 cells/well) and cultured at 37°C. For induction of insulin resistance, 3T3-L1 adipocytes were treated with RHAc, dRHAc, and RHAg for 2 days. Then, cells were washed with freshly made, prewarmed PBS and incubated with 10 μmol/L of 2,7-dichlorofluorescein diacetate (DCFH-DA) dye for 30 min at 37°C. Then, cells were washed twice with PBS and harvested with 0.25% trypsin solution. Released intracellular ROS was detected by a FACSAria flow cytometer at wavelengths of 470/530 nm (ex/em). The data are presented as the mean fluorescent signal of 20,000 cells.
As for the detection of the mitochondrial ROS, DCFH-DA was replaced by 5 μM of MitoSOX reagent (Thermo Fisher Scientific, Beijing, China) and detected at wavelengths of 510/580 nm (ex/em).
2.8. Measurement of ATP Levels
Cells were pretreated as described in Section 2.7. After induction of insulin resistance and treatment with RHAc, dRHAc, and RHAg, cells were washed twice with ice-cold PBS and harvested with 0.25% trypsin solution. The level of ATP was determined by a spectrophotometer (Spectra MRTM, Dynex Technologies, Chantilly, VA, USA) and an ATP bioluminescence assay kit (Beyotime Biotech Co., Beijing, China) according to the manufacturer’s instructions.
2.9. Monitoring of Mitochondrial Membrane Potential
Cells were pretreated as described in Section 2.8, harvested with 0.25% trypsin solution, and washed twice with PBS. Then, cells were resuspended in warm DPBS containing 10 μM of JC-1 (Sigma-Aldrich) and incubated at 37°C for 30 min. Next, cells were washed once with prewarmed PBS and centrifuged (1000 ×g, 5 min). Then, cells were gently resuspended and analyzed on a FACSAria flow cytometer with 488 nm excitation.
2.10. Statistical Analysis
Data are presented as the mean ± SD from three independent experiments. Statistical analysis was performed by one-way ANOVA or Student’s t-test using statistical analysis software SPSS version 18.0 (SPSS, Chicago, IL, USA). was considered statistically significant.
3.1. Cell Viability Assay
The cytotoxicity of polyphenol stilbenes was measured by the extracellular LDH assay in the media (shown in Figure 3(a)). We found that polyphenol stilbenes did not have obvious effects on the viability of 3T3-L1 preadipocytes at the tested concentrations of 0.1–10 μmol/L for 48 hr. Thus, the concentration of three polyphenol stilbenes were confirmed as 10 μmol/L in the following experiments. And 1 μmol/L rosiglitazone was used as a positive control.
3.2. Lipogenesis and TG Assay
During the differentiation of 3T3-L1 preadipocytes to adipocytes, the formation of lipid droplets is a typical phenomenon that is used as a marker of differentiation . Lipid droplets in differentiated 3T3-L1 adipocytes were stained by Oil Red O. Figure 3(b) shows that more big droplets were observed in fully differentiated 3T3-L1 cells when compared to undifferentiated control cells. This indicated that obvious lipogenesis occurred during differentiation. Treatment with both RHAc and dRHAc significantly decreased the accumulation of lipid droplets. To quantify the intracellular lipid content, TG levels were determined. The results presented in Figure 3(c) showed that during differentiation, treatment with RHAc, dRHAc, and RHAg significantly inhibited cellular TG accumulation ( or ). The TG content in RHAc and dRHAc-treated cells was significantly lower compared with mature cells. These data indicated that polyphenol stilbenes differently reduced lipid accumulation during the differentiation of 3T3-L1 adipocytes.
3.3. Expression of Adipocyte-Specific Protein during 3T3-L1 Differentiation
Adipocyte differentiation from 3T3-L1 preadipocytes is associated with the expression of adipocyte-specific genes including FAS, C/EBPα, and PPARγ . Therefore, we investigated the expression of these proteins (Figure 3(d)). In preadipocytes, these proteins were all expressed at a low level and were significantly increased in mature adipocytes. In general, RHAc suppressed the expression of all these proteins, and dRHAc and RHAg increased the levels of FAS and PPARγ. Together, these data indicated that the different effects of polyphenol stilbenes on the adipogenesis were tightly associated with their modulations on the expression of adipocyte-specific proteins during adipocyte differentiation.
3.4. 2-NBDG Uptake
To investigate the effects of polyphenol stilbenes on glucose uptake in insulin-resistant (IR) 3T3-L1 adipocytes, the fluorescent deoxyglucose analog (2-NBDG) was used to measure the rates of glucose uptake. 2-NBDG has been wildly used in various studies, especially for exploring cellular metabolic functions associated with GLUT systems . As shown in Figure 4(a), 2-NBDG uptake in the IR group significantly decreased. Rosiglitazone (Rosi), known as a positive drug for the treatment of insulin resistance, significantly increased insulin-stimulated glucose uptake in 3T3-L1 adipocytes at the concentration of 1 μmol/L. These data suggested that establishing the IR model in this study was successful. Treatment with RHAc and dRHAc enhanced the uptake of glucose compared with the IR group.
3.5. P-AKT and P-AMPK Expression
In previous studies, it has been reported that both Akt and AMPK signaling are critical for controlling metabolic disorders, especially in the insulin signaling cascade through glucose transport . We determined the expression of total Akt and phospho-Akt Ser473 as well as total AMPK and phospho-AMPK Thr172 by Western blot analysis to elucidate how polyphenol stilbenes promote glucose uptake in IR 3T3-L1 adipocytes.
Data presented in Figure 4(b) demonstrate the effects of polyphenol stilbenes on the activation of AKT and AMPK. Our results demonstrated that both the phosphorylation of AKT and AMPK were significantly decreased in IR adipocytes. Insulin at 100 nmol/L significantly stimulated Akt and AMPK activity. Rosi (1 μmol/L), a well-known AMPK activator used in this study significantly reversed the reduction of AMPK phosphorylation. Moreover, RHAc treatment showed a more remarkable effect than the other two compounds. As expected, we demonstrated that treatment with polyphenol stilbenes increased ATP levels in IR 3T3-L1 adipocytes (Figure 5(a)).
3.6. Detection of ROS Levels
Recent studies have suggested that several naturally derived active components could prevent metabolic diseases. During adipocyte proliferation and differentiation, the generation of ROS was related to the activation of AMPK . Therefore, in this study, we evaluated the production of ROS by using DCFH-DA dye. As shown in Figure 5(a), intracellular ROS was rapidly upregulated in IR adipocytes. Under the same conditions, treatment with different compounds had different effects on the production of ROS. For example, Rosi and RHAc significantly reduced the expression of ROS (), whereas RHAg did not have obvious effects on intracellular ROS.
Mitochondria are the main providers but also the main scavengers of cell oxidative stress. Therefore, we monitored mitochondrial ROS by measuring the fluorescence of MitoSOX. Figure 5(b) showed that mitochondrial ROS of IR adipocytes was significantly elevated by approximately 40% when compared with mature adipocytes. Treatment with Rosi and polyphenol stilbenes had obvious effects on the scavenging of mitochondrial ROS ( or ). Taken together, RHAc had the most significant effect on inhibiting the generation of ROS, no matter it is intracellular or mitochondrial.
3.7. ATP Production and Mitochondrial Membrane Potential
Mitochondria are the “power houses” of eukaryotic cells. The main function of mitochondria is to produce the cellular energy source, ATP. Thus, ATP production and the membrane potential can be used to evaluate mitochondrial function. The membrane-permeant JC-1 dye is widely used to monitor mitochondrial health. The JC-1 dye produces potential-dependent accumulation in mitochondria, as indicated by a shift in fluorescence emission from green (~529 nm) to red (~590 nm). Consequently, mitochondrial depolarization is indicated by a decrease in the ratio of red/green fluorescence intensity . The data presented in Figure 6 suggested that the mitochondrial function of IR adipocytes was significantly damaged (). Both Rosi and RHAc could significantly increase ATP production and the mitochondrial membrane potential. However, the effects of RHAc were better compared to that of Rosi. These findings were consistent with the ROS scavenging ability of the compounds evaluated previously, which had been shown in Figure 5.
Type 2 diabetes mellitus (T2DM) has become one of the world’s most important public health problems. Insulin resistance seems to be attributed to the progressive failure of T2DM and metabolic syndrome . Adipocytes play a central role in maintaining lipid homeostasis and energy balance . Induced 3T3-L1 preadipocytes can differentiate into mature adipocytes, which are widely used to investigate glucose and lipid metabolism in adipocytes in vitro . To fight against metabolic disorders, scientific research is focused on effective functional natural molecules from herbals, fruits, and vegetables . Among these molecules, stilbenes, a group of polyphenols have received great interest in recent years. In our previous study, we demonstrated that extracts from stilbenes from fenugreek have beneficial hypoglycemic effects in diabetic mice, and three polyphenol stilbenes (RHAc, dRHAc, and RHAg) were separated from fenugreek seeds by HSCCC . Therefore, in the current study, we further explored the effects of these polyphenol stilbenes on lipogenesis and glucose uptake in IR 3T3-L1 adipocytes.
The data presented here showed that these stilbenes could inhibit lipid accumulation during 3T3-L1 differentiation by suppressing adipocyte-specific proteins at a concentration of 10 μmol/L. In addition, glucose uptake was differently improved after treatment with the three compounds. When comparing the effects of the compounds used, RHAc had the best effect. RHAc significantly stimulated the activation of Akt and AMPK in IR 3T3-L1 adipocytes. However, RHAg had the lowest activity despite its structure contains 3 phenolic hydroxyl groups.
It has been shown that the antiradical and the hydrogen peroxide scavenging activities by phenolic compounds positively correlate with both the position and number of hydroxyl groups bound with the aromatic ring [36, 37]. Moreover, structure-activity relationship analysis indicated that the therapeutic effects of natural phenols involve the reduction of ROS and include polyphenol stilbenes . After the hypoglycemic activity of these stilbenes was confirmed, we further investigated both the intracellular and mitochondrial ROS production in IR 3T3-L1 adipocytes (Figure 5). Oxidative stress is closely linked with the development of T2DM  and ROS can suppress the insulin response and contribute to the development of insulin resistance, a key pathological feature of T2DM . Our results regarding ROS measurements supported this conclusion. It seemed likely that the activation of AKT and AMPK was related to the production of ROS . With regard to the polyphenol stilbenes, ROS generation in the RHAc-treated group was significantly reduced. This is consistent with the structure-activity relationship of these compounds in ROS scavenging. Moreover, compounds with a strong ROS clearing ability may also activate the AMPK and other related pathways . Eventually, this would lead to inefficient modulation of the glucose and lipid metabolism, as demonstrated by RHAc in this study. Lipid accumulation and impaired glucose uptake are related to the weakened metabolic capacity of mitochondria in IR adipocytes. Several natural active products, such as RHAc improved mitochondrial function, enhanced insulin sensitivity, and promoted the metabolism of carbohydrates and fatty acids.
In conclusion, our results demonstrated that polyphenol stilbenes isolated from fenugreek seeds showed marked improvement in insulin sensitivity and mitochondrial function in 3T3-L1 adipocytes. RHAc possessed the best effects in vitro. Moreover, the results strongly indicated that mitochondria play a major role in insulin resistance and related signaling activation. In the future, we will focus on mitochondrial biogenesis and function to explore the underlying mechanism of action.
Conflicts of Interest
The authors report no competing interests.
Gang Li and Guangxiang Luan contributed equally to this work.
This work was supported by the National Science Foundation of China (31470426, 31300292), “Personalized Medicines-Molecular Signature-based Drug Discovery and Development”, Strategic Priority Research Program of the Chinese Academy of Sciences (Grant no. XDA12040320), the Shandong Provincial Science Foundation (ZR2017MH024), the Shuangbai Project of Yantai, Qinghai Provincial Science Foundation (2016-ZJ-929Q, 2015-SF-121), and the Youth Innovation Promotion Association of Chinese Academy of Sciences.
S. N. Acharya, J. E. Thomas, and S. K. Basu, “Fenugreek, an alternative crop for semiarid regions of North America,” Crop Science, vol. 48, no. 3, pp. 841–853, 2008.View at: Publisher Site | Google Scholar
K. Srinivasan, “Fenugreek (Trigonella foenum-graecum): a review of health beneficial physiological effects,” Food Reviews International, vol. 22, no. 2, pp. 203–224, 2006.View at: Publisher Site | Google Scholar
M. Akbari, H. Rasouli, and T. Bahdor, “Physiological and pharmaceutical effect of fenugreek: a review,” IOSR Journal of Pharmacy (IOSRPHR), vol. 2, no. 4, pp. 49–53, 2012.View at: Publisher Site | Google Scholar
U. C. S. Yadav and N. Z. Baquer, “Pharmacological effects of Trigonella foenum-graecum L. in health and disease,” Pharmaceutical Biology, vol. 52, no. 2, pp. 243–254, 2014.View at: Publisher Site | Google Scholar
O. Belguith-Hadriche, M. Bouaziz, K. Jamoussi, M. S. J. Simmonds, A. El Feki, and F. Makni-Ayedi, “Comparative study on hypocholesterolemic and antioxidant activities of various extracts of fenugreek seeds,” Food Chemistry, vol. 138, no. 2-3, pp. 1448–1453, 2013.View at: Publisher Site | Google Scholar
H. Pandey and P. Awasthi, “Effect of processing techniques on nutritional composition and antioxidant activity of fenugreek (Trigonella foenum-graecum) seed flour,” Journal of Food Science and Technology, vol. 52, no. 2, pp. 1054–1060, 2015.View at: Publisher Site | Google Scholar
T. Zia, S. N. Hasnain, and S. K. Hasan, “Evaluation of the oral hypoglycaemic effect of Trigonella foenum-graecum L. (methi) in normal mice,” Journal of Ethnopharmacology, vol. 75, no. 2-3, pp. 191–195, 2001.View at: Publisher Site | Google Scholar
W. L. Xue, X. S. Li, J. Zhang, Y. H. Liu, Z. L. Wang, and R. J. Zhang, “Effect of Trigonella foenum-graecum (fenugreek) extract on blood glucose, blood lipid and hemorheological properties in streptozotocin-induced diabetic rats,” Asia Pacific Journal of Clinical Nutrition, vol. 16, Supplement 1, pp. 422–426, 2007.View at: Google Scholar
A. Eidi, M. Eidi, and M. Sokhteh, “Effect of fenugreek (Trigonella foenum-graecum L) seeds on serum parameters in normal and streptozotocin-induced diabetic rats,” Nutrition Research, vol. 27, no. 11, pp. 728–733, 2007.View at: Publisher Site | Google Scholar
N. Hamza, B. Berke, C. Cheze et al., “Preventive and curative effect of Trigonella foenum-graecum L. seeds in C57BL/6J models of type 2 diabetes induced by high-fat diet,” Journal of Ethnopharmacology, vol. 142, no. 2, pp. 516–522, 2012.View at: Publisher Site | Google Scholar
R. D. Sharma, T. C. Raghuram, and N. S. Rao, “Effect of fenugreek seeds on blood glucose and serum lipids in type I diabetes,” European Journal of Clinical Nutrition, vol. 44, no. 4, pp. 301–306, 1990.View at: Google Scholar
A. Stark and Z. Madar, “The effect of an ethanol extract derived from fenugreek (Trigonella foenum-graecum) on bile acid absorption and cholesterol levels in rats,” British Journal of Nutrition, vol. 69, no. 1, pp. 277–287, 1993.View at: Publisher Site | Google Scholar
S. Kaviarasan, P. Viswanathan, and C. V. Anuradha, “Fenugreek seed (Trigonella foenum graecum) polyphenols inhibit ethanol-induced collagen and lipid accumulation in rat liver,” Cell Biology and Toxicology, vol. 23, no. 6, pp. 373–383, 2007.View at: Publisher Site | Google Scholar
B. Bin-Hafeez, R. Haque, S. Parvez, S. Pandey, I. Sayeed, and S. Raisuddin, “Immunomodulatory effects of fenugreek (Trigonella foenum graecum L.) extract in mice,” International Immunopharmacology, vol. 3, no. 2, pp. 257–265, 2003.View at: Publisher Site | Google Scholar
S. Nathiya, M. Durga, and T. Devasena, “Therapeutic role of Trigonella foenum-graecum [fenugreek]–a review,” International Journal of Pharmaceutical Sciences Review and Research, vol. 27, no. 2, pp. 74–80, 2014.View at: Google Scholar
A. Mehrafarin, A. Qaderi, S. H. Rezazadeh, H. Naghdi Badi, G. H. Noormohammadi, and E. S. Zand, “Bioengineering of important secondary metabolites and metabolic pathways in fenugreek (Trigonella foenum-graecum L.),” Journal of Medicinal Plants, vol. 9, no. 35, pp. 1–18, 2010.View at: Google Scholar
R. Yang, H. Wang, G. Li, Y. Suo, and J. You, “Optimization of ultrasonic-assisted extraction of flavonoids from fenugreek (Trigonella foenum-graecum L.) using response surface methodology and HPLC-DAD-MS analysis,” Asian Journal of Chemistry, vol. 26, no. 15, pp. 4830–4834, 2014.View at: Google Scholar
Y. He, H. Lv, X. Wang, Y. Suo, and H. Wang, “Isolation and purification of six bioactive compounds from the seeds of Trigonella foenum-graecum L. using high-speed counter-current chromatography,” Separation Science and Technology, vol. 49, no. 4, pp. 580–587, 2014.View at: Publisher Site | Google Scholar
Y. He, C. Ding, X. Wang, H. Wang, and Y. Suo, “Using response surface methodology to optimize countercurrent chromatographic separation of polyphenol compounds from fenugreek (Trigonella foenum-graecum L.) seeds,” Journal of Liquid Chromatography & Related Technologies, vol. 38, no. 1, pp. 29–35, 2014.View at: Publisher Site | Google Scholar
Y. He, X. Wang, Y. Suo, C. Ding, and H. Wang, “Efficient protocol for isolation of rhaponticin and rhapontigenin with consecutive sample injection from fenugreek (Trigonella foenum-graecum L.) by HSCCC,” Journal of Chromatographic Science, vol. 54, no. 3, pp. 479–485, 2016.View at: Publisher Site | Google Scholar
D. Pereira, P. Valentão, J. Pereira, and P. Andrade, “Phenolics: from chemistry to biology,” Molecules, vol. 14, no. 6, pp. 2202–2211, 2009.View at: Publisher Site | Google Scholar
M. Reinisalo, A. Kårlund, A. Koskela, K. Kaarniranta, and R. O. Karjalainen, “Polyphenol stilbenes: molecular mechanisms of defence against oxidative stress and aging-related diseases,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 340520, 24 pages, 2015.View at: Publisher Site | Google Scholar
J. Chang, A. Rimando, M. Pallas et al., “Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease,” Neurobiology of Aging, vol. 33, no. 9, pp. 2062–2071, 2012.View at: Publisher Site | Google Scholar
X. Y. Li, S. S. Lu, H. L. Wang et al., “Effects of the fenugreek extracts on high-fat diet-fed and streptozotocin-induced type 2 diabetic mice,” Animal Models and Experimental Medicine, vol. 1, no. 1, pp. 68–73, 2018.View at: Publisher Site | Google Scholar
G. Luan, Y. Wang, Z. Wang et al., “Flavonoid glycosides from fenugreek seeds regulate glycolipid metabolism by improving mitochondrial function in 3T3-L1 adipocytes in vitro,” Journal of Agricultural and Food Chemistry, vol. 66, no. 12, pp. 3169–3178, 2018.View at: Publisher Site | Google Scholar
K. L. Anil Kumar and A. R. Marita, “Troglitazone prevents and reverses dexamethasone induced insulin resistance on glycogen synthesis in 3T3 adipocytes,” British Journal of Pharmacology, vol. 130, no. 2, pp. 351–358, 2000.View at: Publisher Site | Google Scholar
E. D. Rosen, C. J. Walkey, P. Puigserver, and B. M. Spiegelman, “Transcriptional regulation of adipogenesis,” Genes & Development, vol. 14, no. 11, pp. 1293–1307, 2000.View at: Google Scholar
M. Lee, H. H. Lee, J. K. Lee, S. K. Ye, S. H. Kim, and S. H. Sung, “Anti-adipogenic activity of compounds isolated from Idesia polycarpa on 3T3-L1 cells,” Bioorganic & Medicinal Chemistry Letters, vol. 23, no. 11, pp. 3170–3174, 2013.View at: Publisher Site | Google Scholar
C. Zou, Y. Wang, and Z. Shen, “2-NBDG as a fluorescent indicator for direct glucose uptake measurement,” Journal of Biochemical and Biophysical Methods, vol. 64, no. 3, pp. 207–215, 2005.View at: Publisher Site | Google Scholar
S. M. Schultze, B. A. Hemmings, M. Niessen, and O. Tschopp, “PI3K/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis,” Expert Reviews in Molecular Medicine, vol. 14, p. e1, 2012.View at: Publisher Site | Google Scholar
P. V. A. Babu, D. Liu, and E. R. Gilbert, “Recent advances in understanding the anti-diabetic actions of dietary flavonoids,” The Journal of Nutritional Biochemistry, vol. 24, no. 11, pp. 1777–1789, 2013.View at: Publisher Site | Google Scholar
S. Perry, J. Norman, J. Barbieri, E. Brown, and H. Gelbard, “Mitochondrial membrane potential probes and the proton gradient: a practical usage guide,” BioTechniques, vol. 50, no. 2, pp. 98–115, 2011.View at: Publisher Site | Google Scholar
J. Szendroedi, E. Phielix, and M. Roden, “The role of mitochondria in insulin resistance and type 2 diabetes mellitus,” Nature Reviews Endocrinology, vol. 8, no. 2, pp. 92–103, 2011.View at: Publisher Site | Google Scholar
G. Frühbeck, J. Gómez-Ambrosi, F. J. Muruzábal, and M. A. Burrell, “The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation,” American Journal of Physiology-Endocrinology and Metabolism, vol. 280, no. 6, pp. E827–E847, 2001.View at: Publisher Site | Google Scholar
M. J. Thomson, M. G. Williams, and S. C. Frost, “Development of insulin resistance in 3T3-L1 adipocytes,” Journal of Biological Chemistry, vol. 272, no. 12, pp. 7759–7764, 1997.View at: Publisher Site | Google Scholar
Z. Sroka and W. Cisowski, “Hydrogen peroxide scavenging, antioxidant and anti-radical activity of some phenolic acids,” Food and Chemical Toxicology, vol. 41, no. 6, pp. 753–758, 2003.View at: Publisher Site | Google Scholar
Y.-Z. Cai, M. Sun, J. Xing, Q. Luo, and H. Corke, “Structure–radical scavenging activity relationships of phenolic compounds from traditional Chinese medicinal plants,” Life Sciences, vol. 78, no. 25, pp. 2872–2888, 2006.View at: Publisher Site | Google Scholar
T. Perecko, V. Jancinova, K. Drabikova, R. Nosal, and J. Harmatha, “Structure-efficiency relationship in derivatives of stilbene. Comparison of resveratrol, pinosylvin and pterostilbene,” Neuroendocrinology Letters, vol. 29, no. 5, pp. 802–805, 2008.View at: Google Scholar
J. L. Rains and S. K. Jain, “Oxidative stress, insulin signaling, and diabetes,” Free Radical Biology and Medicine, vol. 50, no. 5, pp. 567–575, 2011.View at: Publisher Site | Google Scholar
T. Tiganis, “Reactive oxygen species and insulin resistance: the good, the bad and the ugly,” Trends in Pharmacological Sciences, vol. 32, no. 2, pp. 82–89, 2011.View at: Publisher Site | Google Scholar
J.-a. Kim, Y. Wei, and J. R. Sowers, “Role of mitochondrial dysfunction in insulin resistance,” Circulation Research, vol. 102, no. 4, pp. 401–414, 2008.View at: Publisher Site | Google Scholar